Education
About Us
Working with TipRanks
Follow Us
Bernard Coulie Insider Profile
4 Followers
Bernard Coulie, President & CEO, Director at Pliant Therapeutics, holds 1.00M shares in Pliant Therapeutics (Ticker: PLRX), holds ― shares in SQZ Biotechnologies (Ticker: SQZB).
Bernard Coulie Pliant Therapeutics (PLRX)President & CEO, Director
Pliant Therapeutics (PLRX)
President & CEO, Director
Ranked #36,191 out of 100,956 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+29.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bernard Coulie holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 09, 2020 - Jun 09, 2021
Return:+44.80%
The most profitable trade made by Bernard Coulie
Bernard Coulie's Trading History
Pliant Therapeutics
Jan 27, 2025
President & CEO, Director
Uninformative Buy
―
$1.62M
SQZ Biotechnologies
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Bernard Coulie's performance on stock
You May Also Like
Bernard Coulie insider profile FAQ
What is the percentage of profitable transactions made by Bernard Coulie?
The percentage of profitable transactions made by Bernard Coulie is 100%.
What is the average return per transaction made by Bernard Coulie?
The average return per transaction made by Bernard Coulie is 29.90%.
What stocks does Bernard Coulie hold?
Bernard Coulie holds: PLRX, SQZB stocks.
What was Bernard Coulie’s latest transaction?
Bernard Coulie latest transaction was an Uninformative Buy of ―.
What was Bernard Coulie's most profitable transaction?
Bernard Coulie’s most profitable transaction was an Informative Buy of PLRX stock on June 9, 2020. The return on the trade was 44.80%.
What is Bernard Coulie's role in Pliant Therapeutics?
Bernard Coulie's role in Pliant Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.